The utility of intraoperative ECoG in tumor-related epilepsy: Systematic review

Clin Neurol Neurosurg. 2022 Jan:212:107054. doi: 10.1016/j.clineuro.2021.107054. Epub 2021 Nov 20.

Abstract

Object: Epilepsy is one of the most common clinical manifestations of primary brain tumors. Intraoperative electrocorticography (ECoG) has been widely used in tumor resection. We aim to describe the indication and utility of ECoG during brain tumor surgery.

Methods: We performed a systematic review of the literature on the prognosis of tumor-related epilepsy surgery guided by intraoperative ECoG. The published studies were searched in PubMed, Embase, and Web of Science using the keyword 'seizure' or 'epilepsy' and 'electrocorticography' or 'ECoG'. Two reviewer authors screened studies and extracted data independently.

Results: Thirteen studies included 569 patients were finally selected, of which eight investigated medically intractable epilepsy. Three publications described temporal tumor-related epilepsy. All included studies were retrospective, and the age of all patients ranged from 1 to 71 years. The duration of epilepsy ranged from 1 month to 30 years. Patients with tumor-related epilepsy underwent surgical treatment with Engel I outcomes ranging from 56.5%-100%.

Conclusion: Intraoperative ECoG is generally considered a useful technique in delineating epileptogenic areas and improving the prognosis of surgical treatment of tumor-related epilepsy. However, large-scale randomized control trials are still needed to verify these findings and formulate appropriate surgical strategies.

Keywords: Brain tumor-related epilepsy; Epileptogenic zones; Intraoperative electrocorticography; Lesionectomy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Brain Neoplasms / complications*
  • Electrocorticography* / standards
  • Epilepsy / diagnosis*
  • Epilepsy / etiology
  • Epilepsy / surgery*
  • Humans
  • Intraoperative Neurophysiological Monitoring* / standards